Technical Analysis for TLOG - Tetralogic Pharmaceu

Grade Last Price % Change Price Change
grade C 0.0241 -10.07% -0.0027
TLOG closed down 10.07 percent on Tuesday, June 30, 2020, on 1.24 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical TLOG trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish -10.07%
Crossed Above 50 DMA Bullish -10.07%
MACD Bullish Signal Line Cross Bullish -10.07%
180 Bullish Setup Bullish Swing Setup -10.07%
Wide Bands Range Expansion -10.07%
Fell Below 20 DMA Bearish 26.18%
Older signals for TLOG ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.
Biopharmaceutical Life Sciences Organ Systems Infectious Diseases Autoimmune Diseases Cutaneous T Cell Lymphoma Histone Deacetylase Small Molecule Therapies

Is TLOG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.1
52 Week Low 0.0141
Average Volume 14,957
200-Day Moving Average 0.0430
50-Day Moving Average 0.0227
20-Day Moving Average 0.0247
10-Day Moving Average 0.0241
Average True Range 0.0068
ADX 19.45
+DI 33.0463
-DI 18.9451
Chandelier Exit (Long, 3 ATRs ) 0.0194
Chandelier Exit (Short, 3 ATRs ) 0.0386
Upper Bollinger Band 0.0352
Lower Bollinger Band 0.0142
Percent B (%b) 0.47
BandWidth 85.0202
MACD Line 0.0005
MACD Signal Line 0.0004
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0282
Resistance 3 (R3) 0.0286 0.0277 0.0275
Resistance 2 (R2) 0.0277 0.0267 0.0275 0.0272
Resistance 1 (R1) 0.0259 0.0260 0.0255 0.0255 0.0270
Pivot Point 0.0250 0.0250 0.0248 0.0248 0.0250
Support 1 (S1) 0.0232 0.0240 0.0228 0.0228 0.0212
Support 2 (S2) 0.0223 0.0233 0.0221 0.0210
Support 3 (S3) 0.0205 0.0223 0.0207
Support 4 (S4) 0.0201